The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > Insulin resistant hypertensive rat model

Insulin resistant hypertensive rat model

A model of insulin resistance associated with hypertension leading to early kidney dysfunction

key benefits

  • A proprietary diet induced model : take advantage of Physiogenex’s unique expertise with this model.
  • Assess the efficacy of your compound in a physiological and diet-induced model displaying major features of the onset of diabetic nephropathy in association with insulin resistance, hypertension.
  • Physiological model relevant to the main classes of approved anti-diabetic, anti-hypertensive compounds.

pharmacological validation

  • Positive reference compounds: exendin, metformin, ramipril

Fact sheet

Insulin resistant hypertensive rat model

REFERENCES

Prunet- Maracssus B. et al. Prediabetes and Metabolic Syndrome Congress, 2011.